The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
The Epitopes Targeted by the Rheumatoid Arthritis-Associated Antifilaggrin Autoantibodies are Posttranslationally Generated on Various Sites of (Pro)Filaggrin by Deimination of Arginine Residues
Abstract
Antifilaggrin autoantibodies (AFA) are a population of IgG autoantibodies associated to rheumatoid arthritis (RA), which includes the so-called “antikeratin” Abs and antiperinuclear factor. AFA are the most specific serological markers of RA. We previously showed that they recognize human epidermal filaggrin and other profilaggrin-related proteins of various epithelial tissues. Here, we report further characterization of the protein Ags and epitopes targeted by AFA. All the Ags that exhibit numerous neutral/acidic isoelectric variants were immunochemically demonstrated to be deiminated proteins. In vitro deimination of a recombinant human filaggrin by a peptidylarginine deiminase generated AFA epitopes on the protein. Moreover, two of three filaggrin-derived synthetic peptides with a citrulline in the central position were specifically and widely recognized by AFA affinity-purified from a series of RA sera. These results indicate that citrulline residues are constitutive of the AFA epitopes, but only in the context of specific amino acid sequences of filaggrin. In competition experiments, the two peptides abolished the AFA reactivity of RA sera, showing that they present major AFA epitopes. These data should help in the identification of a putative deiminated AFA-inducing or cross-reactive articular autoantigen and provide new insights into the pathogenesis of RA. They could also open the way toward specific immunosuppressive and/or preventive therapy of RA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arnett, F. C., Edworthy, S. M., Bloch, D. A., Mcshane, D. J., Fries, J. F., Cooper, N. S., Healey, L. A., Kaplan, S. R., Liang, M. H., Luthra, H. S., et al. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310302 · Cited by 19,752
Schellekens, G. A., de Jong, B. A., van den Hoogen, F. H., van de Putte, L. B., & van Venrooij, W. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1316 · Cited by 1,450
Boers, M., Verhoeven, A. C., Markusse, H. M., van de Laar, M. A., Westhovens, R., van Denderen, J. C., van Zeben, D., Dijkmans, B. A., Peeters, A. J., Jacobs, P., et al. (1997) · The Lancet · doi:10.1016/s0140-6736(97)01300-7 · Cited by 1,073
New Serum Factor in Patients with Rheumatoid Arthritis: The Antiperinuclear Factor
Nienhuis, R. L. F., Mandema, E., & Smids, C. (1964) · Annals of the Rheumatic Diseases · doi:10.1136/ard.23.4.302 · Cited by 367
Protein Unfolding by Peptidylarginine Deiminase
Tarcsa, E., Marekov, L. N., Mei, G., Melino, G., Lee, S.-C., & Steinert, P. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.48.30709 · Cited by 350
Sebbag, M., Simon, M., Vincent, C., Masson-Bessière, C., Girbal, E., Durieux, J. J., & Serre, G. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117969 · Cited by 344
Self-citationAnti-keratin antibodies in rheumatoid arthritis.
Young, B. J., Mallya, R. K., Leslie, R. D., Clark, C. J., & Hamblin, T. J. (1979) · BMJ · doi:10.1136/bmj.2.6182.97 · Cited by 336
Myelin in multiple sclerosis is developmentally immature.
Moscarello, M. A., Wood, D. D., Ackerley, C., & Boulias, C. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117300 · Cited by 315
Cellular and Molecular Biology of Intermediate Filaments
(1990) · Springer eBooks · doi:10.1007/978-1-4757-9604-9 · Cited by 264
Simon, M., Girbal, E., Sebbag, M., Gomès-Daudrix, V, Vincent, C., Salama, G., & Serre, G. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116713 · Cited by 262
Self-citationHarding, C. R., & Scott, I. R. (1983) · Journal of Molecular Biology · doi:10.1016/s0022-2836(83)80126-0 · Cited by 239
Utz, P. J., Hottelet, M., Schur, P. H., & Anderson, P. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.5.843 · Cited by 222
Wood, D. D., & Moscarello, M. A. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83707-3 · Cited by 202
Wucherpfennig, K. W., Catz, I., Hausmann, S., Strominger, J. L., Steinman, L., & Warren, K. G. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119622 · Cited by 191
Organization, structure, and polymorphisms of the human profilaggrin gene
Gan, S. Q., McBride, O. W., Idler, W. W., Markova, N., & Steinert, P. M. (1990) · Biochemistry · doi:10.1021/bi00492a018 · Cited by 186
The Sa system: a novel antigen-antibody system specific for rheumatoid arthritis.
Després, N., Boire, G., López-Longo, F. J., & Ménard, H. A. (1994) · PubMed · Cited by 181
Detection of citrulline residues in deiminated proteins on polyvinylidene difluoride membrane
Senshu, T., Sato, T., Inoue, T., Akiyama, K., & Asaga, H. (1992) · Analytical Biochemistry · doi:10.1016/0003-2697(92)90047-b · Cited by 168
Self-citationThe lag time between onset of symptoms and diagnosis of rheumatoid arthritis
Chan, K. A., Felson, D. T., Yood, R. A., & Walker, A. M. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780370606 · Cited by 146
Senshu, T., Akiyama, K., Kan, S., Asaga, H., Ishigami, A., & Manabe, M. (1995) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12317070 · Cited by 140
Self-citationImmunopathology of rheumatoid arthritis
Kurki, P., Aho, K., Palosuo, T., & Heliövaara, M. (1992) · Arthritis & Rheumatism · doi:10.1002/art.1780350810 · Cited by 126
McKinley-Grant, L. J., Idler, W. W., Bernstein, I. A., Parry, D. A. D., Cannizzaro, L. A., Croce, C. M., Huebner, K., Lessin, S. R., & Steinert, P. M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.13.4848 · Cited by 124
Deimination of Human Myelin Basic Protein by a Peptidylarginine Deiminase from Bovine Brain
Lamensa, J. W. E., & Moscarello, M. A. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03612.x · Cited by 111
Scott, I. R., & Harding, C. R. (1981) · Biochimica et Biophysica Acta (BBA) - Protein Structure · doi:10.1016/0005-2795(81)90224-5 · Cited by 84
Mastronardi, F. G., Mak, B. C., Ackerley, C., Roots, B. I., & Moscarello, M. A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118422 · Cited by 42
Monoclonal Antibodies to Human Epidermal Filaggrin, Some Not Recognizing Profilaggrin
Simon, M., Sebbag, M., Haftek, M., Vincent, C., Girbal‐Neuhauser, E., Rakotoarivony, J., Schmitt, D., Serre, G., & Somme, G. (1995) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12321148 · Cited by 38
Self-citationPeptidylarginine deiminase in rat and mouse hemopoietic cells
Nagata, S., & Senshu, T. (1990) · Cellular and Molecular Life Sciences · doi:10.1007/bf01955420 · Cited by 25
Self-citationMyelin Basic Protein Autoantibodies
Li, S. (1996) · Elsevier eBooks · doi:10.1016/b978-044482383-0/50080-7 · Cited by 3
Cited by
Smolen, J. S., Aletaha, D., & McInnes, I. B. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30173-8 · Cited by 4,870
Schellekens, G. A., Visser, H., De Jong, B. A. W., Van Den Hoogen, F. H. J., Hazes, J. M. W., Breedveld, F. C., & Van Venrooij, W. J. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200001)43:1<155::aid-anr20>3.0.co;2-3 · Cited by 1,450
Coeliac disease: dissecting a complex inflammatory disorder
Sollid, L. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri885 · Cited by 964
The etiology of rheumatoid arthritis
Scherer, H. U., Häupl, T., & Burmester, G. R. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.102400 · Cited by 881
Masson-Bessière, C., Sebbag, M., Girbal-Neuhauser, E., Nogueira, L., Vincent, C., Senshu, T., & Serre, G. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.6.4177 · Cited by 643
Self-citation
Metadata
- Authors
- Girbal-Neuhauser, E., Durieux, J.-J., Arnaud, M., Dalbon, P., Sebbag, M., Vincent, C., Simon, M., Senshu, T., Masson-Bessière, C., Jolivet-Reynaud, C., Jolivet, M., & Serre, G.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-01-01
- Volume
- 162
- Issue
- 1
- Pages
- 585-594
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1582204239
- Cited by
- 485
- References
- 27
- FWCI
- 12.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.